Septerna to present at td cowen 45th annual health care conference

South san francisco, calif., feb. 26, 2025 (globe newswire) -- septerna, inc. (nasdaq: sepn), a biotechnology company pioneering a new era of g protein-coupled receptor (gpcr) drug discovery, today announced that jeffrey finer, m.d.
COWN Ratings Summary
COWN Quant Ranking